Skip to content

600867.SH

通化东宝

SSE · Healthcare · Drug Manufacturers - General · CN

CNY 7.95
−1.97%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue3.0B2.9B2.0B3.1B2.8B
Cost of Revenue886.8M874.5M524.5M612.8M617.5M
Gross Profit2.2B2.1B1.5B2.5B2.2B
Operating Expenses
R&D Expense165.3M167.1M99.3M105.0M146.7M
SG&A Expense
General & Admin Expense177.2M180.9M182.6M134.5M180.6M
Selling & Marketing Expense1.1B1.1B1.1B912.8M933.5M
Other Expenses
Total Operating Expenses1.5B1.5B1.4B1.2B1.3B
Cost and Expenses2.4B2.4B1.9B1.8B1.9B
Operating Income (EBIT)1.6B1.6B169.7M1.4B1.8B
Non-Operating
Interest Income
Interest Expense
Net Interest Income
Other Non-Op Income/Expense
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)1.5B1.5B(142.3M)1.4B1.8B
Income Tax Expense317.5M280.1M(99.6M)198.0M247.7M
Bottom Line
Net Income1.2B1.2B(42.0M)1.2B1.6B
Earnings from Cont. Ops1.2B1.2B(42.5M)1.2B1.6B
Earnings from Discont. Ops
Bottom Line Net Income1.2B1.2B(42.0M)1.2B1.6B
Per Share
Basic EPSCN¥0.62CN¥0.62(CN¥0.02)CN¥0.59CN¥0.79
Diluted EPSCN¥0.62CN¥0.62(CN¥0.02)CN¥0.59CN¥0.79
Revenue Per ShareCN¥1.44CN¥1.50CN¥0.96CN¥1.55CN¥1.39
Shares
Basic Shares Outstanding2.1B2.0B2.1B2.0B2.0B
Diluted Shares Outstanding2.1B2.0B2.1B2.0B2.0B
Profitability Metrics
EBITDA1.9B373.5M1.6B2.0B
D&A293.7M203.8M185.3M133.9M
EBIT

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026